Cancer organoid-based diagnosis reactivity prediction (CODRP) index-based anticancer drug sensitivity test in ALK-rearrangement positive non-small cell lung cancer (NSCLC)

BACKGROUND: Recently, cancer organoid-based drug sensitivity tests have been studied to predict patient responses to anticancer drugs. The area under curve (AUC) or IC(50) value of the dose-response curve (DRC) is used to differentiate between sensitive and resistant patient‘s groups. This study pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Sang-Yun, Cho, Hyeong Jun, Choi, Jimin, Ku, Bosung, Moon, Seok Whan, Moon, Mi Hyoung, Kim, Kyung Soo, Hyun, Kwanyong, Kim, Tae-Jung, Sung, Yeoun Eun, Hwang, Yongki, Lee, Eunyoung, Ahn, Dong Hyuck, Choi, Joon Young, Lim, Jeong Uk, Park, Chan Kwon, Kim, Sung Won, Kim, Seung Joon, Koo, In-Seong, Jung, Woo Seok, Lee, Sang-Hyun, Yeo, Chang Dong, Lee, Dong Woo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10664561/
https://www.ncbi.nlm.nih.gov/pubmed/37993887
http://dx.doi.org/10.1186/s13046-023-02899-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10664561/
https://www.ncbi.nlm.nih.gov/pubmed/37993887
http://dx.doi.org/10.1186/s13046-023-02899-4

Ejemplares similares